Integrated BioPharma, Inc.: Integrated BioPharma Announces C

HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Board

Related Keywords

United States , Ukraine , America , Dina Masi , Christina Kay , Damon Desantis , Riva Sheppard , Carl Desantis , Biopharma Inc , Celsius Holding Inc , Rexall Sundown Nutritional Company , Company Board Of Directors , Executives Officers Of The Company , Nasdaq , Integrated Biopharma , Classi Director , Co Chief Executives Officers , North America , Celsius Holding , Chief Executive Officer , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Integrated , Iopharma , Nnounces , Change , Directors ,